Covid jabs have prevented more than 52,000 hospital admissions in England
He mentioned: “Today we have new data from Public Health England that estimates the vaccination programme in England alone has prevented 52,600 hospitalisations.
“That is up 6,300 from three weeks in the past, a becoming instance of the protecting wall that our vaccination programme has given us – a wall that is getting stronger day-after-day.
“It is this protection that has allowed us to carefully ease restrictions over the past few months.”
Latest figures present 88 per cent of adults have acquired a primary dose, whereas 69 per cent have had their second. Mr Zahawi mentioned the nation may very well be pleased with the uptake.
But he warned there have been nonetheless many individuals unprotected, together with 34 per cent of individuals aged 18-29, who have not but had a jab.
He added: “I would like to once again urge everyone to come forward and get both doses to protect yourselves, protect your loves ones and your community.
“Our battle in opposition to this virus is just not the type of battle the place we will merely declare victory and transfer on with our lives.
“Instead we must learn to live with the virus, doing whatever we can to slow its spread while we maintain the vital defences that will keep us safe.”
Public Health England’s weekly surveillance report confirmed virus case charges amongst individuals aged 20-29 had reached the best stage recorded because the begin of the pandemic, with a seven-day rate of 1154.7 per 100,000 inhabitants.
Case charges have been lowest among the many over 80s, at 60.6 per 100,000 inhabitants.
Dr Yvonne Doyle, PHE’s medical director, warned that Covid-19 had not gone away.
She mentioned: “Case rates in people aged 20-29 are at the highest across any age group recorded since the pandemic began.
“Everyone in this age group ought to come ahead and get their two doses of the vaccine to verify they have the most effective probability of being protected.”
Nadhim Zahawi said the jab rollout was strengthening our defences
Health chiefs are also encouraging pregnant women to get the vaccine. PHE data showed 51,724 women who reported that they were or could be pregnant at the time of their jab had received at least one dose.
Of those, 20,649 had also received their second jab.
Meanwhile, experts investigating the effect of different dosing regimes for the Pfizer/BioNTech vaccine said the UK’s decision to bring second doses forward to eight weeks after the first had hit the “candy spot”.
A study led by the University of Oxford compared the levels of antibodies generated after doses were given at three and 10-week intervals.
Although both led to good responses, the longer gap led to 2.3- fold higher levels of neutralising antibodies against the Delta variant.
Researchers said the Joint Committee on Vaccination and Immunisation’s (JCVI) decision to reduce the maximum gap between doses from 12 to eight weeks struck a balance.
Dr Lance Turtle, of the University of Liverpool, said: “It’s a compromise between desirous to have as many individuals immunised as quick as doable versus getting the best response doable.
“There is a trade-off.”
Professor Susanna Dunachie, of Oxford University, added: “I think that eight weeks is about the sweet spot for me, because people do want to get the two vaccine [doses] and there is a lot of Delta out there right now.
“Unfortunately, I am unable to see this virus disappearing so that you wish to steadiness that in opposition to getting the most effective safety which you could.”
The study recruited 503 healthcare workers and looked at how their antibody and T-cell levels changed after each dose of vaccine.
After two doses, T-cell levels were around 40 per cent lower in people on the longer schedule.
However, in those participants, a higher proportion of the T cells were so-called “helper” T cells, which are important for long-term immune memory and helping generate antibodies to prevent infection.
A separate study suggested booster vaccines may be needed, after researchers detected a drop in antibody levels after second doses.
In a research letter published in The Lancet, they described how levels of antibodies targeting the spike protein began to wane within 3-10 weeks.
However, experts stressed that it is not yet clear what level of antibodies is needed for protection and how quickly more would be produced if participants became infected.
A further 39,906 Covid-19 cases were confirmed across the UK yesterday, down 18 per cent compared to the previous Thursday.
It was the first time in over two months that the daily figure had fallen when compared to the same day a week earlier.
The number of cases reported in the last seven days was up 24 per cent compared to the previous week. However, this was lower than increases of around 40 per cent in the seven-day total seen on previous days.
Paul Hunter, professor in medicine, at the University of East Anglia, cautioned that the apparent slowing of cases may only be temporary and the real gauge of the relaxations of July 19 will not start to be seen until towards the end of next week.
He said: “It will not be till August 9 earlier than we all know for sure.”
There have been 84 Covid-19 deaths reported yesterday, up from 63 every week earlier.
The seven-day complete for deaths linked to the virus had elevated by 50 per cent in comparison with the earlier week.